# A Study of CIN-107 in Patients With Uncontrolled Hypertension

> **NCT05137002** · PHASE2 · COMPLETED · sponsor: **CinCor Pharma, Inc.** · enrollment: 249 (actual)

## Conditions studied

- Uncontrolled Hypertension

## Interventions

- **DRUG:** CIN-107
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05137002
- **Lead sponsor:** CinCor Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-07
- **Primary completion:** 2022-09-13
- **Final completion:** 2022-10-10
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05137002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05137002, "A Study of CIN-107 in Patients With Uncontrolled Hypertension". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05137002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*